Literature DB >> 22133626

Improvement of prostate treatment by anterior proton fields.

Shikui Tang1, Stefan Both, Hassan Bentefour, Jonathan J Paly, Zelig Tochner, Jason Efstathiou, Hsiao-Ming Lu.   

Abstract

PURPOSE: We performed a treatment planning study to demonstrate the potential dosimetric benefits of anterior-oriented fields for prostate irradiation by proton beam. A novel in vivo beam range control method shows millimeter accuracy, suggesting that such fields could be safely used to spare the rectum given the sharp distal penumbra of protons. METHODS AND MATERIALS: Ten prostate patients treated with water-filled endorectal balloon were selected. Bilateral fields were planned following the conventional treatment protocol. Three anterior-oriented fields (0, +30, -30°) were planned, with the range compensators manually adjusted to improve rectal sparing. Dose distributions to the clinical target volume, rectum, anterior rectal wall (ARW), bladder, bladder wall (BW), and femoral heads were compared for: A) equally weighted bilateral fields, B) a single straight anterior field, and C) two equally weighted anterior-oblique fields.
RESULTS: The anterior-oriented fields required much less beam energy, ∼10 cm water equivalent path length less than lateral fields. For ARW, the V(95%) for Plans A, B, and C were 39%, 8%, and 6%, respectively; the corresponding V(80%) were 59%, 27%, and 26%, respectively (p = 0.002 when Plan A was compared with B or C). Plan B irradiated a larger volume of BW than did Plan A by 3% at V(95%), 11% at V(80%), and 16% at V(50%) (p = 0.002), whereas Plan C differs little from Plan A for BW at these dose levels. The femoral heads received ∼40% of the prescription dose in Plan A, but negligible dose in Plans B and C.
CONCLUSIONS: Compared to lateral fields, anterior-oriented fields can significantly reduce dose to the ARW, particularly at high dose levels. These fields alone, or in combination with lateral fields, allow for the possibility of either reducing treatment toxicity at current prescription doses or further dose escalation in the treatment of prostate cancer.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22133626     DOI: 10.1016/j.ijrobp.2011.06.1974

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  21 in total

1.  A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer.

Authors:  Maryam Moteabbed; Alexei Trofimov; Gregory C Sharp; Yi Wang; Anthony L Zietman; Jason A Efstathiou; Hsiao-Ming Lu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-12-29       Impact factor: 7.038

2.  Validation of an in-vivo proton beam range check method in an anthropomorphic pelvic phantom using dose measurements.

Authors:  El H Bentefour; Shikui Tang; Ethan W Cascio; Mauro Testa; Deepak Samuel; Damien Prieels; Bernard Gottschalk; Hsiao-Ming Lu
Journal:  Med Phys       Date:  2015-04       Impact factor: 4.071

Review 3.  Proton beam radiation therapy for prostate cancer-is the hype (and the cost) justified?

Authors:  Phillip J Gray; Jason A Efstathiou
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092

Review 4.  Proton beam and prostate cancer: An evolving debate.

Authors:  Anthony Zietman
Journal:  Rep Pract Oncol Radiother       Date:  2013-07-03

Review 5.  In vivo range verification in particle therapy.

Authors:  Katia Parodi; Jerimy C Polf
Journal:  Med Phys       Date:  2018-11       Impact factor: 4.071

6.  Uncertainty incorporated beam angle optimization for IMPT treatment planning.

Authors:  Wenhua Cao; Gino J Lim; Andrew Lee; Yupeng Li; Wei Liu; X Ronald Zhu; Xiaodong Zhang
Journal:  Med Phys       Date:  2012-08       Impact factor: 4.071

7.  Scanned ion beam therapy for prostate carcinoma: Comparison of single plan treatment and daily plan-adapted treatment.

Authors:  Sebastian Hild; Christian Graeff; Antoni Rucinski; Klemens Zink; Gregor Habl; Marco Durante; Klaus Herfarth; Christoph Bert
Journal:  Strahlenther Onkol       Date:  2015-11-27       Impact factor: 3.621

Review 8.  Clinical controversies: proton therapy for prostate cancer.

Authors:  Kent W Mouw; Alexei Trofimov; Anthony L Zietman; Jason A Efstathiou
Journal:  Semin Radiat Oncol       Date:  2013-04       Impact factor: 5.934

9.  Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions.

Authors:  Chuan Zeng; Drosoula Giantsoudi; Clemens Grassberger; Saveli Goldberg; Andrzej Niemierko; Harald Paganetti; Jason A Efstathiou; Alexei Trofimov
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

10.  The effect of anterior proton beams in the setting of a prostate-rectum spacer.

Authors:  John P Christodouleas; Shikui Tang; Robert C Susil; Todd R McNutt; Danny Y Song; Justin Bekelman; Curtiland Deville; Neha Vapiwala; Theodore L Deweese; Hsiao-Ming Lu; Stefan Both
Journal:  Med Dosim       Date:  2013-04-08       Impact factor: 1.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.